Cure My Disease

Don't miss your cure!

Log in / Sign up

← Back to home

Gilva Therapeutics Inc.

Clinical trials sponsored by Gilva Therapeutics Inc., explained in plain language.

Upcoming readouts

Trials from this sponsor expected to report results within the next 12 months.

Could a pill tame polycystic kidney disease? early safety trial begins Results expected Mar 2027 (estimated)

Browse trials soon ready across all sponsors →

Trials to join now! 1

Could a pill tame polycystic kidney disease? early safety trial begins

Knowledge-focused Recruiting now

This early-stage trial is the first to test GV-100, an oral drug being developed for autosomal dominant polycystic kidney disease (ADPKD), in healthy volunteers. The study aims to assess the drug's safety, tolerability, and how the body processes it, including the effects of food…

Phase 1 • Sponsor: Gilva Therapeutics Inc. • Aim: Knowledge-focused

Last updated Aug 28, 2026 00:00 UTC